Detalles de la búsqueda
1.
Perceptions around bone-modifying agent use in patients with bone metastases from breast and castration resistant prostate cancer: a patient survey.
Support Care Cancer
; 29(11): 6903-6912, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34023950
2.
Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers.
Oncologist
; 25(10): e1509-e1515, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32735386
3.
Development and Implementation of a Continuing Medical Education Program in Canada: Knowledge Translation for Renal Cell Carcinoma (KT4RCC).
J Cancer Educ
; 34(1): 14-18, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28779441
4.
Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Cancer
; 124(18): 3677-3683, 2018 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30307610
5.
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial.
Lancet
; 387(10031): 1909-20, 2016 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26952546
6.
Real-world Assessment of Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma with or Without Sarcomatoid Features Treated with First-line Systemic Therapies.
Eur Urol Oncol
; 7(3): 570-580, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38097481
7.
Adjuvant therapy for renal cell carcinoma: 2023 Canadian Kidney Cancer Forum consensus statement.
Can Urol Assoc J
; 17(5): E154-E163, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37185210
8.
UnCHAARTED territory: The role of docetaxel rechallenge following chemohormonal therapy for metastatic castration-sensitive prostate cancer.
Urol Oncol
; 40(12): 539.e17-539.e22, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36272847
9.
Outcomes of Radiation Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System.
Adv Radiat Oncol
; 7(4): 100899, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35814860
10.
Outcomes of Cytoreductive Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Real World Data from Canadian Centers.
Eur Urol Focus
; 8(6): 1703-1710, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34736870
11.
Primary skull-based yolk-sac tumour: case report and review of central nervous system germ cell tumours.
J Neurooncol
; 101(1): 129-34, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20503065
12.
Surgical Management of Genitourinary Cancer Liver Metastases.
Surg Oncol Clin N Am
; 30(1): 89-102, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33220811
13.
Stereotactic Radiotherapy in the Treatment of Paraneoplastic Vasculitis in Oligometastatic Renal Cell Carcinoma.
Curr Oncol
; 28(3): 1744-1750, 2021 05 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34066912
14.
Real-world management of advanced prostate cancer: A description of management practices of community-based physicians and prostate cancer specialists.
Can Urol Assoc J
; 15(2): E90-E96, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32853135
15.
A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer.
Eur J Cancer
; 142: 132-140, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33023785
16.
Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival.
JAMA Netw Open
; 4(1): e2021869, 2021 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33475752
17.
Results from a Canadian consensus forum of key controversial areas in the management of advanced prostate cancer: Recommendations for Canadian healthcare providers.
Can Urol Assoc J
; 15(10): 353-358, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34125066
18.
Docetaxel dose-intensity effect on overall survival in patients with metastatic castrate-sensitive prostate cancer.
Cancer Chemother Pharmacol
; 85(5): 863-868, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32240336
19.
Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome-Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Eur Urol Oncol
; 3(4): 530-539, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32037304
20.
Controversial issues in the management of patients with advanced prostate cancer: Results from a Canadian consensus forum.
Can Urol Assoc J
; 14(4): E137-E149, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31702544